Group 1 - Company Gongchuang Turf (605099.SH) stated that the impact of domestic football events on its operations and performance is minimal, as its main business of artificial turf has a low revenue contribution from domestic sports grass [1] - Company Anglikang (002940.SZ) confirmed that its innovative drug project ALK-N001 is still in Phase I clinical trials, indicating a long R&D cycle and significant investment [2] - Company Yiwei Lithium Energy (300014.SZ) plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance capital strength and international brand image [3] Group 2 - Company Chaohongji (002345.SZ) also intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange to advance its global strategy and improve competitiveness [4] - Company Dexin Technology (603032.SH) clarified that its subsidiary's sales revenue from products used in solid-state battery production is less than 1% of total revenue, emphasizing its focus on quality service [5] - Company Changshan Pharmaceutical (300255.SZ) announced that its application for the marketing authorization of Aibennapeptide injection for type 2 diabetes has been accepted, but the approval timeline remains uncertain [6] Group 3 - Company Baili Electric (600468.SH) reported that its revenue from nuclear fusion-related business is currently minimal, accounting for less than 1% of total revenue [7] - Company Chutianlong (003040.SZ) is exploring digital currency projects but faces risks related to new technology development and commercial application [8] - Company Dongxing Medical (301290.SZ) signed contracts with Shanghai Jiao Tong University for synthetic biology technology development, totaling 6 million yuan, enhancing its R&D capabilities [9] Group 4 - Company Maixinlin (688685.SH) announced that its subsidiary signed contracts for computing power services worth 1.184 billion yuan, expected to positively impact future performance [10] - Company Haichen Pharmaceutical (300584.SZ) reported that its solid-state battery-related business has not yet generated revenue, which does not significantly affect overall performance [11] - Company Filinger (603226.SH) is undergoing stock trading suspension for investigation due to significant price deviations from fundamentals [12] Group 5 - Company Zhongdian Port (001287.SZ) disclosed that the National Integrated Circuit Fund reduced its stake by 1%, now holding 8.97% of the company [13] - Company Huasheng Co., Ltd. (600156.SH) is planning to acquire 100% of Yixin Technology, leading to a stock suspension for up to 10 trading days [14] - Company Jianghuai Automobile reported a 3.52% year-on-year decline in May sales, with new energy vehicle sales down 57.81% [15] - Company Aonong Biological reported a 9.44% year-on-year increase in May pig sales, with a total of 156,200 pigs sold [16]

一、 复盘点评： 沪指再次站上 3400 ，量能站上 1.3 万亿，科技风偏正在回归 1. 大盘指数走势及成交量强度表现 AI 方向全线异动 ：天孚通信、中际旭创表现强劲， 粤传媒和引力传媒涨停，港股尾盘 AI 应用大涨， 资金持续回补科技主线。 今日 A 股市场整体呈现强势震荡上行格局，沪指上涨 0.43% ， 重新站上 3400 点整数关口，实现 " 五连阳 " ，创业板指表现更为强劲，涨 幅达 1.07% ，反映出市场风险偏好提升。沪深两市成交额达 1.31 万亿元，较前一交易日显著放量超 1350 亿元，放量上涨显示做多资金持 续活跃，量能配合良好，市场动能充沛。 主力资金净流入明显，重点流入方向为医药、新能源、人工智能与国企改革方向。主力净流入个股中，东方财富、中际旭创、恒瑞医药、天孚 通信等龙头表现突出，显示资金更倾向于高景气 + 产业趋势明确 + 技术逻辑支撑的赛道 核心标的 。 | 体育 | | | 文娱用品 | | | 金属新材料 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | - ...

多家银行理财管理费调降 部分有条件少收或不收 在存款利息下调后，银行理财等产品迎来大量增量资金。记者近日实地探访了深圳的线下银行网点了解 到，多家银行展开新一轮理财降费，部分产品管理费有条件少收或不收，希望通过费率优惠吸引投资者 认购理财产品。银行经理对记者表示，有些产品做了让利处理已经在收益净值里体现了。（一财） Canalys：2026年或成为折叠屏市场复苏的关键年 Canalys预计2025全年折叠屏手机出货量仅能实现0.1%的同比增长。虽然2025年主流厂商试图通过采取 降低售价、扩展SKU等方式来寻求增长，但整体需求依旧承压。2026年或成为折叠屏市场复苏的关键 年，苹果传闻中的折叠产品将有望带动整体品类的讨论度，并可能在软件交互与硬件设计层面带来新的 思考，进一步活化市场需求。（新浪财经） 机构：Q1淡季效应减轻 晶圆代工营收季减至5.4% 今年前五个月我国实施儿童用品召回超20万件 从市场监管总局了解到，为消除儿童用品安全隐患，切实守护儿童健康成长，今年1到5月，我国共实施 缺陷儿童用品召回132次，涉及数量20.08万件。其中，儿童玩具召回54次，涉及数量9.66万件；儿童服 装召回40次，涉 ...

从个股表现来看，今天上涨个股超4100家，下跌个股1000余家，涨停个股87家，跌停个股3家，可以看出今天算是一个普涨行情。从连板情绪来看， 上周五2连板及以上个股12家，今天真正晋级的只有4家，还有一家菲林格尔收盘竞价达到涨停价，但是没有封死，晋级率比较差，且2连板5家没有1 家晋级3连板，这在今天普涨的行情中也是非常少见的，算的上是一个罕见奇观了。不过目前市场有一个好的情况是：如联化科技、均瑶健康、菲林 格尔等这些周末都是被监控或是有利空的个股，今天还能涨停，说明短线情绪开始起来了。 盘面上来看，我在昨天的文章中提到的要关注"可控核聚变的反弹修复、足球概念、以及创新药、稳定币的资金回流修复等"。那么反观今天的市场表 现，可以说最强的就是创新药板块，创新药概念再度爆发，舒泰神、常山药业、海辰药业、睿智医药、联化科技、众生药业等多股涨停。消息面上， 国家药监局批准11款全新创新药的上市申请，另外还有2款创新药拟纳入优先审评，新品种密集获批有望赶上今年医保谈判放量，为相关企业业绩增 长提供助力。 另外，足球概念持续活跃，康力源20cm涨停、粤传媒涨停、共创草坪6连板，金陵体育涨超15%。可控核聚变午后活跃，百利 ...

证券代码：000969 证券简称：安泰科技 安泰科技股份有限公司投资者关系活动记录表 编号：2025-007 | |  特定对象调研 分析师会议 | | --- | --- | | 投资者关系 | 媒体采访 业绩说明会 | | 活动类别 | 新闻发布会 路演活动 | | | 现场参观其他 | | 参与单位名 | 中泰军工-陈鼎如；泓德基金-刘运昌；中骏基金-吴道滨；中邮基金-孟东 晖；东北证券-王凤华；昊泽致远-于航；沣京资本-李正强；银杏资本 | | | 张海军；方正资管-聂贻哲；东方基金-李瑞；兴合基金-孙祺；长城资 | | | 管-胡纪元；中信建投-高吉涛；银华基金-丁婧；光大永明-沈繁呈；新 | | 称及人员姓 | 华基金-王永明；招商信诺-柴若琪；鸿竹资产-费征帅；长江证券-臧雄； | | 名 | 长江证券-杨继虎；中邮基金-白鹏；中邮基金-刘星辰；玄元投资-陈剑 博；安联资管-彭婷；山西证券资管-李培玉；新华资产-吴昊；鹏华基 | | | 金-曾欣；太平洋基金-宋小浪；中银基金-张欣仪；浙商资管基金-庞雅 | | | 菁；银河基金-金寿鹏、国新国证基金-毕子男；中银资管-王瑾；上海 ...

Core Insights - The market experienced a significant surge with over 4100 stocks rising, and more than 100 stocks increasing by over 9% on June 9, indicating a broad-based rally across various sectors [1] - A total of 65 stocks hit the daily limit up, with 13 stocks in consecutive limit-up trading, showcasing strong investor sentiment and market momentum [1] - Notable stocks include Gongchuang Turf, which achieved a six-day consecutive limit-up, and Lianhua Technology, which saw a remarkable 112% increase over the last ten trading days [1] Stock Performance - Gongchuang Turf reached a six-day consecutive limit-up, reflecting a 100% advancement rate in its category [2] - Jinshi Technology achieved five consecutive limit-ups, with a 50% advancement rate in its category [2] - Zhongjiabo Chuang recorded four consecutive limit-ups, also with a 50% advancement rate [2] - Other notable limit-up stocks include Zhongchao Holdings with 13 consecutive limit-ups and Junyao Health with six limit-ups over ten days [2] Sector Highlights - The innovative drug sector saw a resurgence, with stocks like Anglikang achieving three limit-ups in five days and Changshan Pharmaceutical reaching historical highs [1] - The stablecoin concept gained traction, with Jinshi Technology and Hengbao shares showing strong performances [1] - Other sectors such as solid-state batteries, agricultural chemicals, elderly care robots, sports, controllable nuclear fusion, and rare earth permanent magnets also demonstrated solid performance [1]

Core Viewpoint - A-shares experienced a rebound with all three major indices rising, driven by strong performance in the innovative drug sector and other active sectors like football concepts and internet finance [1] Market Performance - The Shanghai Composite Index rose by 0.43%, the Shenzhen Component increased by 0.65%, and the ChiNext Index gained 1.07% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.31 trillion yuan, an increase of 135.5 billion yuan compared to the previous trading day [1] Sector Highlights - The innovative drug sector saw significant gains, with stocks such as Shuyou Shen, Changshan Pharmaceutical, Haichen Pharmaceutical, Ruizhi Medicine, Lianhua Technology, and Zhongsheng Pharmaceutical hitting the daily limit [1] - The football concept sector remained active, with Co-Creation Turf achieving six consecutive trading limit ups and Jinling Sports rising over 10% [1] - The precious metals sector led the declines, with stocks like Chifeng Gold and Shandong Gold experiencing the largest drops [1] Overall Market Sentiment - The overall market showed a positive trend with more than 4,100 stocks rising, indicating a bullish sentiment among investors [1]

Group 1 - The company has developed nuclear-grade cable products applicable to controlled nuclear fusion [1] - The company is collaborating with relevant units to research and develop cable products for extremely complex nuclear fusion environments [1]

Group 1: Rare Earths - Recent price increases for rare earth elements, with neodymium oxide rising 4.66% to 449,000 CNY/ton, dysprosium oxide up 0.31% to 1,630,000 CNY/ton, and terbium oxide increasing 1.69% to 7,200,000 CNY/ton [1][2] - Significant price surges in overseas markets due to China's export restrictions on seven types of medium and heavy rare earth products, with dysprosium oxide in Europe rising from 250-310 USD/kg to 700-1000 USD/kg (204% increase) and terbium oxide from 930-1000 USD/kg to 2000-4000 USD/kg (211% increase) [1][2] - Domestic prices may follow the trend of antimony prices once companies obtain export licenses, leading to potential further increases in rare earth prices [2] Group 2: Molybdenum - Molybdenum prices have increased, with molybdenum concentrate rising 6.33% to 3,865 CNY/ton and molybdenum iron (Mo60) up 4.01% to 246,500 CNY/ton [3] - Supply-side contraction signals are emerging, while demand remains steady, supporting price increases [3] Group 3: Tungsten - Tungsten prices have reached new highs, with black tungsten concentrate rising 4.88% to 172,000 CNY/ton and ammonium paratungstate up 4.33% to 253,000 CNY/ton [3] - Supply constraints due to reduced mining quotas and stable domestic demand are driving prices higher [3] Group 4: Tin - Tin prices are experiencing fluctuations, with SHFE tin down 0.38% to 263,600 CNY/ton and LME tin down 0.98% to 32,400 USD/ton [4] - Current supply is tight due to low operating rates in Yunnan and the resumption of production at the Bisie tin mine in the Democratic Republic of Congo [4] Group 5: Antimony - Antimony prices are adjusting downward, with antimony ingot prices down 3.37% to 215,000 CNY/ton and antimony concentrate down 3.85% to 187,500 CNY/ton [4] - Supply improvements from logistics recovery at the China-Myanmar border and a 30% increase in imports are contributing to price adjustments [4] Group 6: New Materials - A window for export recovery in new materials has emerged following the easing of tariffs between China and the U.S., with potential for recovery in companies with high export exposure [5] - The agreement includes the cancellation of significant tariffs on Chinese goods, which may benefit new material companies [5] Group 7: Nuclear Fusion Materials - The commercialization of controlled nuclear fusion is accelerating, with upstream materials expected to benefit significantly [6] - Major advancements in both domestic and international nuclear fusion projects indicate a high growth phase for related materials [6]

A：目前 25 年销售目标是在 24 年新签订单的基础上增长 20%，国 内国外各产品线同比例增长。根据目前国内、海外市场需求以及各条产 品线跟踪项目来看，对于 25 年新签订单增长比较有信心。 Q：请问公司产品能否应用于可控核聚变领域？ 杭州中泰深冷技术股份有限公司投资者关系活动记录表 | 投资者关系活动 |  | 特定对象调研 □分析师会议 □媒体采访 □业绩说明会 | | --- | --- | --- | | 类别 | | □新闻发布会 □路演活动 | | | □现场参观 | □其他 | | | | 源峰基金：王奔 星石投资：孔嘉祥 中金证券：鲁烁 | | 参与单位名称及 | | 国金证券机械研究员：李子安 泰康资产机械研究员：张厚喆 | | 人员姓名 | | 华夏基金机械研究员：邓寒 财通基金机械研究员：翁嘉敏 | | | | 财通基金基金经理：张胤 国联证券：张天浩 | | 时间 | 2025 年 | 6 月 6 日 | | 地点 | | 公司会议室——线下会议 | | 上市公司接待 | | 董事会秘书：周娟萍 | | 人员姓名 | | 证券事务代表：凌诗轶 | | | | 公司介绍： | | ...